These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 8513279)

  • 1. Cholecystokinin release in the central nervous system.
    de Belleroche J
    Neurochem Int; 1993 Jun; 22(6):529. PubMed ID: 8513279
    [No Abstract]   [Full Text] [Related]  

  • 2. Release of cholecystokinin in the central nervous system.
    Raiteri M; Paudice P; Vallebuona F
    Neurochem Int; 1993 Jun; 22(6):519-27. PubMed ID: 8513278
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intracerebroventricular administration of cholecystokinin inhibits the activity of the dopaminergic and serotoninergic systems of the brain.
    Vasar EE; Otter MYa ; Ryago LK
    Neurosci Behav Physiol; 1985; 15(3):232-6. PubMed ID: 2993947
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dopamine modulates cholecystokinin release in neostriatum.
    Meyer DK; Krauss J
    Nature; 1983 Jan; 301(5898):338-40. PubMed ID: 6823307
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CCK, schizophrenia, and anxiety. CCK-B antagonists inhibit the activity of brain dopamine neurons.
    Rasmussen K
    Ann N Y Acad Sci; 1994 Mar; 713():300-11. PubMed ID: 8185172
    [No Abstract]   [Full Text] [Related]  

  • 6. Increased anxiety behavior in OLETF rats without cholecystokinin-A receptor.
    Yamamoto Y; Akiyoshi J; Kiyota A; Katsuragi S; Tsutsumi T; Isogawa K; Nagayama H
    Brain Res Bull; 2000 Dec; 53(6):789-92. PubMed ID: 11179844
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of cholecystokinin release from central nerve terminals.
    Ghijsen WE; Leenders AG; Wiegant VM
    Peptides; 2001 Aug; 22(8):1213-21. PubMed ID: 11457513
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Involvement of the neuropeptide cholecystokinin in the mechanisms of regulation of emotions and craving].
    Anokhina IP; Proskuriakova TV
    Vestn Ross Akad Med Nauk; 2002; (6):36-40. PubMed ID: 12116760
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 5-HT and anxiety.
    Iversen SD
    Neuropharmacology; 1984 Dec; 23(12B):1553-60. PubMed ID: 6152028
    [No Abstract]   [Full Text] [Related]  

  • 10. Cholecystokinins in the central nervous system and neurohypophysis.
    Vanderhaeghen JJ; Lotstra F; Vierendeels G; Gilles C; Deschepper C; Verbanck P
    Peptides; 1981; 2 Suppl 2():81-8. PubMed ID: 6283501
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of acetylcholine release by cholecystokinin in striatum: receptor specificity; role of dopaminergic neuronal activity.
    Petkova-Kirova P; Giovannini MG; Kalfin R; Rakovska A
    Brain Res Bull; 2012 Dec; 89(5-6):177-84. PubMed ID: 22981453
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute effects on brain cholecystokinin-like concentration and anxiety-like behaviour in the female rat upon a single injection of 17β-estradiol.
    Holm L; Liang W; Thorsell A; Hilke S
    Pharmacol Biochem Behav; 2014 Jul; 122():222-7. PubMed ID: 24732637
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Minireview. The ascent of cholecystokinin (CCK) - from gut to brain.
    Morley JE
    Life Sci; 1982 Feb; 30(6):479-93. PubMed ID: 6122154
    [No Abstract]   [Full Text] [Related]  

  • 14. Evidence for a differential cholecystokinin-B and -A receptor regulation of GABA release in the rat nucleus accumbens mediated via dopaminergic and cholinergic mechanisms.
    Ferraro L; O'Connor WT; Li XM; Rimondini R; Beani L; Ungerstedt U; Fuxe K; Tanganelli S
    Neuroscience; 1996 Aug; 73(4):941-50. PubMed ID: 8809813
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regional distributions of somatostatin and cholecystokinin-like immunoreactivities in rat and bovine brain.
    Barden N; Mérand Y; Rouleau D; Moore S; Dockray GJ; Dupont A
    Peptides; 1981; 2(3):299-302. PubMed ID: 6117841
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Co-storage in large 'dense-core' vesicles of dopamine and cholecystokinin in rat striatum.
    Llona I; Annaert WG; Jacob W; De Potter WP
    Neurochem Int; 1994 Dec; 25(6):573-81. PubMed ID: 7894334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of dopamine depletion upon the K(+)-evoked release of CCK from superfused striatal slices.
    Sierralta J; Gysling K
    Neurosci Lett; 1990 May; 112(2-3):313-7. PubMed ID: 2113658
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cholecystokinin in the central nervous system.
    Beinfeld MC; Meyer DK; Brownstein MJ
    Peptides; 1981; 2 Suppl 2():77-9. PubMed ID: 6283500
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of a cholecystokinin preparation on brain monoamines in the rat.
    Katsuura G; Hirota R; Itoh S
    Jpn J Physiol; 1980; 30(5):811-4. PubMed ID: 7463880
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurobiology of cholecystokinin.
    Moran TH; Schwartz GJ
    Crit Rev Neurobiol; 1994; 9(1):1-28. PubMed ID: 8828002
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.